remifentanyl is one of 120 small molecule programs targeting Analgesia. It is currently in Preclinical.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
348 competitors in Prostate Cancer
Talzenna
Androgen Deprivation Therapy
Alinamin
Leuprorelin
AAA617
Semaglutide Pen Injector
Gnrh Agonist/antagonist
Piflufolastat F 18
Trexall
Botox
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Sources
Details